天晟新材(300169.SZ):目前暫無超導材料及石墨烯材料的相關業務
格隆匯8月11日丨天晟新材(300169.SZ)發佈股票交易嚴重異常波動公吿,近期有投資者通過互動易平台或投資者電話對公司全資子公司天晟證券有限公司以及公司產品是否包含超導材料及石墨烯材料業務領域十分關注,現就相關情況進行説明:
1、公司全資子公司天晟證券有限公司是一家在香港成立的證券公司,在監管機構許可的範圍內開展業務,包括證券交易及發行債券等業務,公司於2016年9月通過現金收購方式取得其100%股權。
2、公司主營業務為高分子新材料的研究、開發、生產和銷售,目前暫無超導材料及石墨烯材料的相關業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.